Wang, Shuang
Meador, Kimford J.
Pawasauskas, Jayne
Lewkowitz, Adam K.
Ward, Kristina E.
Brothers, Todd N.
Hartzema, Abraham
Quilliam, Brian J.
Wen, Xuerong http://orcid.org/0000-0002-4803-7895
Funding for this research was provided by:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R15HD097588)
Article History
Accepted: 24 November 2022
First Online: 16 January 2023
Declarations
:
: Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number R15HD097588 (Principal Investigator: Dr. Xuerong Wen). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
: Abraham Hartzema is the CSO of Suremed Compliance LLC and received a business grant from the NIH/NIDA (R44DA 051272-01, 08/01/2020–07/31/2023, total budget 1.6M). Kimford J. Meador has received research support from the National Institutes of Health and Sunovion Pharmaceuticals, and travel support from Eisai. The Epilepsy Study Consortium pays Kimford J. Meador’s university for his research consultant time related to Eisai, GW Pharmaceuticals, NeuroPace, Novartis, Supernus, Upsher-Smith Laboratories, and UCB Pharma. Jayne Pawasauskas is on the speakers’ bureau for Heron Therapeutics. Adam K. Lewkowitz is supported by the NICHD (K23 HD103961-A1), and his research is also supported by Essential Hospitals Institute/CVS Health Foundation and Pharmacosmos Therapeutics, Inc. Adam K. Lewkowitz was a paid speaker for Pharmacosmos as well. The other authors have no conflicts of interests that are directly relevant to the content of this article.
: This study was approved and granted a waiver of informed consents by the Institutional Review Board of The University of Rhode Island (IRB 1289357-4) and Rhode Island Department of Health (IRB#: 2019-11).
: Not applicable.
: Not applicable.
: We thank the Rhode Island Department of Health and the Executive Office of Health and Human Services for providing the data access. Restrictions apply to the availability of these data, which were used under license for this study. Data are available from the Rhode Island Department of Health upon appropriate application (ExternalRef removed).
: The codes used in this study are available upon request.
: SW and XW have full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: XW, SW, KJM. Acquisition, analysis, or interpretation of data: SW, XW. Drafting of the manuscript: SW, XW, KJM. Critical revision of the manuscript for important intellectual content: all authors. Statistical analysis: SW. Clinical, technical, or material support: JP, AKL, KEW, TNB, AH, BJQ. Supervision: Wen, KJM. All authors read and approved the final version.